| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |